mk-8353
Showing 1 - 1 of 1
Tumors, Colorectal Cancer Trial in Grand Rapids, Nashville, Kirkland (MK-8353, Pembrolizumab)
Completed
- Neoplasms
- Colorectal Cancer
- MK-8353
- Pembrolizumab
-
Grand Rapids, Michigan
- +2 more
Dec 21, 2022